I am wondering why some protein inhibitors increase the levels of target protein and still known as their inhibitors? For example MCL1 inhibitor S63845 increase the levels of MCL1 in tumor cells (Kotschy et al., Nature 538, 477–482). I understands that these inhibitors mostly act to inhibit protein-protein interactions. Like, in this case S63845 inhibits interaction of MCL1 with BAK and BAX, thereby facilitates the availability of BAK and BAX for downstream apoptotic pathway. But, It always confuses me why it is known as a inhibitor of MCL1?